The risk of medullary thyroid carcinoma in patients with Hirschsprung's disease

被引:0
|
作者
Richard Škába
Šárka Dvořáková
Eliška Václavíková
Petr Vlček
Miroslava Frantlová
Běla Bendlová
机构
[1] Charles University and Hospital Prague—Motol,Department of Pediatric Surgery of the 2nd Faculty of Medicine
[2] Institute of Endocrinology,Department of Molecular Endocrinology
[3] Charles University and Hospital Prague—Motol,Department of Nuclear Medicine and Endocrinology of the 2nd Faculty of Medicine
[4] Charles University and Hospital Prague—Motol,Department of Pathology and Molecular Medicine of the 2nd Faculty of Medicine
来源
Pediatric Surgery International | 2006年 / 22卷
关键词
Hirschsprung's disease; Medullary thyroid carcinoma; RET proto-oncogene; Genetics;
D O I
暂无
中图分类号
学科分类号
摘要
Hirschsprung's disease (HD) can be associated with the development of neuroendocrine tumours such as medullary thyroid carcinoma (MTC). The RET proto-oncogene is the major gene responsible for both HD and MTC. Mutations in exon 10 (codons 609, 611, 618, 620) were found in patients with co-occurrence of HD and MTC. The aim of the study was to screen the MTC risk in patients with HD. The prospective and retrospective genetic analyses comprised 56 HD patients (41 males, 15 females, aged 0–47). The prospective subgroup of patients consisted of 34 patients (25 boys, 9 girls) operated on between June 2003 and December 2005. The retrospective subgroup comprised 22 patients (16 boys, 6 girls) of 194 patients who were operated on between December 1979 and May 2003, non-systematically chosen preferably for total colonic aganglionosis (TCA). DNAs were isolated from blood and resected segments of aganglionic bowel. The HD patients and nine available family members (2 HD) were tested for RET mutations in exons 10, 11, 13, 14, 15 and 16. Direct double-stranded fluorescent sequencing revealed typical germline heterozygous MTC risk RET mutations in 3/56 (5.4%) female HD patients: Cys609Tyr, Cys620Arg (both exon 10) and Tyr791Phe (exon 13). Two of these patients had TCA and one patient had classical type of HD. One TCA patient developed clinical stage of MTC and underwent total thyroidectomy (TTE). The other two RET positive HD patients (aged 7 and 25 years) are screened for calcitonin level and they are without TTE till now. Two family members (mothers of TCA patients) with detected RET mutation underwent prophylactic TTE with MTC finding. Results showed the benefit of systematic RET mutation screening in HD patients in order to identify the risk of MTC in preclinical stage of the disease in patients with HD and their family members. We recommend to investigate not only exon 10 but also exon 13.
引用
收藏
页码:991 / 995
页数:4
相关论文
共 50 条
  • [31] Prolonging survival of patients with medullary thyroid carcinoma
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 (7): : 364 - 364
  • [32] Surgical strategies in patients with medullary thyroid carcinoma
    Sorrenti, S.
    Guaitoli, E.
    Catania, A.
    D' Andrea, V.
    Di Matteo, F. M.
    Nardi, M.
    Prinzi, N.
    Nardi, F.
    Ascoli, V.
    Baldini, E.
    Ulisse, S.
    De Antoni, E.
    CLINICA TERAPEUTICA, 2012, 163 (05): : E303 - E306
  • [33] Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma
    Magnani, P
    Paganelli, G
    Songini, C
    Samuel, A
    Sudati, F
    Siccardi, AG
    Fazio, F
    BRITISH JOURNAL OF CANCER, 1996, 74 (05) : 825 - 831
  • [34] SCINTIGRAPHIC STUDIES IN PATIENTS WITH MEDULLARY CARCINOMA OF THE THYROID
    RASMUSSON, B
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1982, 7 (04): : 150 - 151
  • [35] CYTOGENETIC STUDIES ON PATIENTS WITH MEDULLARY CARCINOMA OF THE THYROID
    LECONIAT, M
    VECCHIONE, D
    PACOT, A
    BERNHEIM, A
    BERGER, R
    GARDET, P
    PARMENTIER, C
    CANCER GENETICS AND CYTOGENETICS, 1987, 25 (02) : 303 - 307
  • [36] BONE ABNORMALITIES IN PATIENTS WITH MEDULLARY CARCINOMA OF THE THYROID
    RASMUSSON, B
    ACTA RADIOLOGICA ONCOLOGY, 1980, 19 (06): : 461 - 465
  • [37] WHEN IS MEDULLARY-THYROID CARCINOMA MEDULLARY-THYROID CARCINOMA
    RICCABONA, G
    LADURNER, D
    SCHMID, K
    WORLD JOURNAL OF SURGERY, 1986, 10 (05) : 745 - 752
  • [38] Risk factors for medullary thyroid carcinoma: a pooled analysis
    Negri, E
    Ron, E
    Franceschi, S
    La Vecchia, C
    Preston-Martin, S
    Kolonel, L
    Kleinerman, RA
    Mabuchi, K
    Jin, F
    Wingren, G
    Hallquist, A
    Levi, F
    Linos, A
    Fraumeni, JF
    CANCER CAUSES & CONTROL, 2002, 13 (04) : 365 - 372
  • [39] Risk factors for medullary thyroid carcinoma: a pooled analysis
    Eva Negri
    Elaine Ron
    Silvia Franceschi
    Carlo La Vecchia
    Susan Preston-Martin
    Laurence Kolonel
    Ruth A. Kleinerman
    Kiyohiko Mabuchi
    Fan Jin
    Gun Wingren
    Arne Hallquist
    Fabio Levi
    Athena Linos
    Joseph F. Fraumeni
    Cancer Causes & Control, 2002, 13 : 365 - 372
  • [40] Prevalence and Clinical Spectrum of Nonsecretory Medullary Thyroid Carcinoma in a Series of 839 Patients with Sporadic Medullary Thyroid Carcinoma
    Frank-Raue, Karin
    Machens, Andreas
    Leidig-Bruckner, Gudrun
    Rondot, Susanne
    Haag, Christine
    Schulze, Egbert
    Lorenz, Angela
    Kreissl, Michael C.
    Dralle, Henning
    Raue, Friedhelm
    Schmid, Kurt W.
    THYROID, 2013, 23 (03) : 294 - 300